Cargando…
Economic Impact of Antidiabetic Medications and Glycemic Control on Managed Care Organizations: A Review of the Literature
OBJECTIVES: To review the recent literature (January 2000-November 2005) regarding the impact of antidiabetic medications and glycemic control on the overall costs of care for patients with diabetes in U.S. managed care organizations (MCOs). SUMMARY: The pharmacy component accounts for typically 20%...
Autores principales: | Stephens, Jennifer M., Botteman, Marc F., Hay, Joel W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437381/ https://www.ncbi.nlm.nih.gov/pubmed/16515371 http://dx.doi.org/10.18553/jmcp.2006.12.2.130 |
Ejemplares similares
-
The burden of managing pleural effusions in patients with chronic myelogenous leukemia post-imatinib failure: A literature-based economic analysis
por: Stephens, Jennifer, et al.
Publicado: (2010) -
Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review
por: Evans, Marc, et al.
Publicado: (2021) -
Nonglycemic Outcomes of Antidiabetic Medications
por: Morse, Christopher, et al.
Publicado: (2019) -
Trends in the Economics and Organization of Medical Care
por: Weinerman, E. Richard
Publicado: (1963) -
Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab
por: Xu, Yifan, et al.
Publicado: (2018)